Real-time enrollment status for this essential thrombocythemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06456346 |
| Recruiting Status | Recruiting |
| Condition | Essential Thrombocythemia |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | February 20, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06456346 is currently recruiting participants. This clinical trial study for essential thrombocythemia is actively seeking new participants at 13 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06456346 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06456346 was last updated 1 week ago (February 20, 2026). HelloStudys verifies this status automatically.